BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 35382890)

  • 21. Price transparency implementation: Accessibility of hospital chargemasters and variation in hospital pricing after CMS mandate.
    Lu AJ; Chen EM; Vutam E; Brandt J; Sadda P
    Healthc (Amst); 2020 Sep; 8(3):100443. PubMed ID: 32919582
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prices Paid to Hospitals by Private Health Plans Are High Relative to Medicare and Vary Widely: Findings from an Employer-Led Transparency Initiative.
    White C; Whaley CM
    Rand Health Q; 2021 Aug; 9(2):5. PubMed ID: 34484877
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of United States and International Ophthalmic Drug Pricing.
    Gong D; Chang JS; Barbany M; Corcostegui BF; Kağan Değirmenci MF; Ishikawa H; Mammo Z; Ozmert E; Rossi T; Chang S
    Ophthalmology; 2019 Oct; 126(10):1358-1365. PubMed ID: 31146962
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Not Clearing the Air: Hospital Price Transparency for a Laparoscopic Cholecystectomy.
    Green RL; Dunham P; Kling SM; Kuo LE
    J Surg Res; 2022 Dec; 280():501-509. PubMed ID: 36081309
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Variation in Cost of Echocardiography Within and Across United States Hospitals.
    Wei C; Milligan M; Lam M; Heidenreich PA; Sandhu A
    J Am Soc Echocardiogr; 2023 Jun; 36(6):569-577.e4. PubMed ID: 36638930
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tennessee hospital noncompliance with price transparency legislation for 8 common laboratory tests.
    Hart SA; Khan A; Booth GS; Wiencek JR
    Am J Clin Pathol; 2024 May; ():. PubMed ID: 38733607
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of Commercial-to-Medicare Relative Prices With Health System Financial Performance.
    Blavin F; Kane N; Berenson R; Blanchfield B; Zuckerman S
    JAMA Health Forum; 2023 Feb; 4(2):e225444. PubMed ID: 36763368
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hospital-Administered Cancer Therapy Prices for Patients With Private Health Insurance.
    Xiao R; Ross JS; Gross CP; Dusetzina SB; McWilliams JM; Sethi RKV; Rathi VK
    JAMA Intern Med; 2022 Jun; 182(6):603-611. PubMed ID: 35435948
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Variations in Payer-Negotiated Prices for Head and Neck Reconstructive Surgery.
    Wu SS; Rathi VK; Byrne PJ; Fritz MA; Shaye DA; Lee LN; Sethi RKV; Lindsay RW; Xiao R
    Otolaryngol Head Neck Surg; 2023 Nov; 169(5):1154-1162. PubMed ID: 37337449
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does managed competition constrain hospitals' contract prices? Evidence from the Netherlands.
    Douven R; Burger M; Schut F
    Health Econ Policy Law; 2020 Jul; 15(3):341-354. PubMed ID: 30973119
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ongoing Challenges With Price Transparency in Hospital Charges for Hand Procedures.
    Rhee BS; Kalliainen LK
    J Hand Surg Am; 2023 Dec; 48(12):1263-1267. PubMed ID: 37676189
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Do You Get What You Pay For? The Relationship of Price and Quality in Hospital Provided Procedures.
    Esposito AC; Laird WD; Zhang Y; Cerullo M; Li AX; Coppersmith NA; Reddy V; Leeds I; Mongiu A; Longo W; Pantel H
    J Surg Res; 2022 Oct; 278():140-148. PubMed ID: 35598497
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Concordance of Disclosed Hospital Prices With Total Reimbursements for Hospital-Based Care Among Commercially Insured Patients in the US.
    Horný M; Shafer PR; Dusetzina SB
    JAMA Netw Open; 2021 Dec; 4(12):e2137390. PubMed ID: 34902037
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Variability in expenses related to spine oncology care: comparison of payer-negotiated rates at National Cancer Institute-Designated Cancer Centers.
    Kasthuri VS; Alsoof D; Balmaceno-Criss M; Daher M; McDonald CL; Diebo BG; Kuris EO; Daniels AH
    Spine J; 2024 Feb; 24(2):304-309. PubMed ID: 38440969
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hospital-Negotiated Pricing of Cochlear Implants.
    Bartholomew RA; Rathi VK; Suresh K; Sethi RKV; Lee DJ; Xiao R
    Otolaryngol Head Neck Surg; 2023 Sep; 169(3):734-737. PubMed ID: 36939617
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparing Medicare Advantage and Traditional Medicare Prices for Hospital Outpatient Services With Hospital Price Transparency Data.
    Xu J; Polsky D
    Med Care Res Rev; 2023 Aug; 80(4):455-461. PubMed ID: 36760138
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Determinants of Commercial Prices for Common Radiation Therapy Procedures.
    Milligan MG; Orav EJ; Lam MB
    Int J Radiat Oncol Biol Phys; 2023 Jan; 115(1):23-33. PubMed ID: 36309073
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Private Payer-Negotiated Prices for Outpatient Otolaryngologic Surgery.
    Wang AA; Xiao R; Sethi RKV; Rathi VK; Scangas GA
    Otolaryngol Head Neck Surg; 2022 Aug; 167(2):262-265. PubMed ID: 34582305
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hospital- and county-level characteristics explain geographic variability in prices of cancer-related procedures: Implications for policy and interventions.
    Moss JL; Ledford SG; Bernacchi V; Shen C
    Cancer Med; 2023 Dec; 13(1):. PubMed ID: 38131646
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Wide State-Level Variation In Commercial Health Care Prices Suggests Uneven Impact Of Price Regulation.
    Chernew ME; Hicks AL; Shah SA
    Health Aff (Millwood); 2020 May; 39(5):791-799. PubMed ID: 32364869
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.